139 - What's Hot in ID + HIV

Saturday, October 2, 2021

1:15 PM - 3:00 PM EDT

Moderator(s)

Wendy Armstrong, MD

Professor of Medicine
Emory University
Atlanta, GA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Joshua Nosanchuk, MD

Professor and Senior Associate Dean
Albert Einstein College of Medicine
Bronx, NY, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

Rajesh Gandhi, MD

Professor of Medicine
Harvard Medical School
Boston, MA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Diane Havlir, MD

Chief
Division of HIV, Infectious Diseases & Global Medicine/School of Medicine/University of California, San Francisco - Zuckerberg San Francisco General Hospital

NIH (Individual(s) Involved: Self): Grant/Research Support
Cynthia Sears, MD

Professor
Johns Hopkins
Baltimore, MD, United States

Bristol Meyer Squibb (BMS) (Individual(s) Involved: Self): Grant/Research Support; Janssen Pharmaceuticals (Individual(s) Involved: Self): Grant/Research Support
Susan Rehm, MD

Vice Chair, Department of Infectious Disease
Cleveland Clinic
Cleveland , OH, United States

Lilly (Individual(s) Involved: Self): Shareholder; Merck (Individual(s) Involved: Self): Shareholder; Pfizer (Individual(s) Involved: Self): Shareholder

Participants should be aware of the following financial/non-financial relationships:

Wendy Armstrong, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Joshua D. Nosanchuk, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Rajesh Gandhi, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Diane V. Havlir, MD: NIH (Individual(s) Involved: Self): Grant/Research Support

Cynthia L. Sears, MD: Bristol Meyer Squibb (BMS) (Individual(s) Involved: Self): Grant/Research Support; Janssen Pharmaceuticals (Individual(s) Involved: Self): Grant/Research Support

Susan J. Rehm, MD: Lilly (Individual(s) Involved: Self): Shareholder; Merck (Individual(s) Involved: Self): Shareholder; Pfizer (Individual(s) Involved: Self): Shareholder

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit

No CPE credits

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe new developments in the field of clinical and epidemiological sciences in HIV
discuss new research findings in the pathogenesis of HIV infection and the host response

Presentations:

What Hot in HIV Basic Science
Speaker: Rajesh Gandhi, MD – Harvard Medical School
What's Hot in HIV Clinical Science
Speaker: Diane V. Havlir, MD – Division of HIV, Infectious Diseases & Global Medicine/School of Medicine/University of California, San Francisco - Zuckerberg San Francisco General Hospital
What's Hot in ID Basic Science
Speaker: Cynthia L. Sears, MD – Johns Hopkins
What's Hot in ID Clinical Science
Speaker: Susan J. Rehm, MD – Cleveland Clinic